The CDC opioid prescribing guidelines do not endorse mandated or abrupt discontinuation of opioid prescriptions. The guidelines recommend tapering only when patient harm outweighs the benefit of opioid therapy. Nonetheless, there are reports of patients being abruptly dropped from their longstanding prescriptions without appropriate tapering or MAT referral.
Please join CMS and the NYHPA for a webinar on November 13th at 1pm on the importance of appropriate tapering of opioids and the role played by MAT.
On the webinar we'll discuss the efforts of payors to support appropriate tapering and MAT, the role of MAT, and how patients can be more effectively linked to treatment services when necessary.
Speakers will include a representative from the CMS Regional Office, Dr. Sandy Koyfman and Dr. Cynthia Miller of Wellcare and Leah Kauffman and her colleague Samantha Arsenault of Shatterproof, a leading nonprofit organization dedicated to ending the devastation addiction causes families. Participants will have ample time to raise concerns and questions during this important conversation.
Register here. Dial-in and login information will be sent in advance of the call. Please share with prescribers, clinicians, and partners who may be interested in logging on or dialing in.